↓ Skip to main content

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain

Overview of attention for article published in BMC Palliative Care, September 2009
Altmetric Badge

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
29 Mendeley